• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC-S 40 REFOBACIN BONE CEMENT R; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC-S 40 REFOBACIN BONE CEMENT R; BONE CEMENT, ANTIBIOTIC Back to Search Results
Catalog Number 4710500394-1
Device Problem Infusion or Flow Problem (2964)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).The device will not be returned to the manufacturer.Therefore it will not be analyzed.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.Investigation results concluded that the product is conform and the root cause is undetermined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly zimmer biomet will continue to monitor for trends.
 
Event Description
It has been reported that the liquor didn´t leave the bag.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.Complaint sample was evaluated and the reported event was confirmed.The device evaluation was performed, the returned product is an optipac with two pouches.The pouches were punctured but did not empty.The plunger was still locked in lower position, when the vaccum test was applied and we noticed that the system was tied, the pouches did not empty.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.No similar complaints have been recorded for optipac-s 40 refobacin bone cement r, reference (b)(4), batch a716d02310 on the reported issue.With the available information, the exact root cause of the event could not be determined.If any further information is found which would change or alter any conclusions or information, a supplemental report will be field accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that the liquid didn´t leave the bag.No adverse events have been reported as a result of the malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC-S 40 REFOBACIN BONE CEMENT R
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8357011
MDR Text Key136854986
Report Number3006946279-2019-00108
Device Sequence Number1
Product Code MBB
UDI-Device Identifier03599870112212
UDI-Public(01)03599870112212
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2018
Device Catalogue Number4710500394-1
Device Lot NumberA716D02310
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/04/2019
Was the Report Sent to FDA? No
Date Manufacturer Received10/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-